Logo image of ALGEV.PA

GEVELOT SA (ALGEV.PA) Stock Fundamental Analysis

Europe - Euronext Paris - EPA:ALGEV - FR0000033888 - Common Stock

178 EUR
-1 (-0.56%)
Last: 12/12/2025, 7:00:00 PM
Fundamental Rating

4

ALGEV gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 110 industry peers in the Machinery industry. While ALGEV has a great health rating, there are worries on its profitability. ALGEV does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year ALGEV was profitable.
In the past year ALGEV had a positive cash flow from operations.
ALGEV had positive earnings in each of the past 5 years.
Of the past 5 years ALGEV 4 years had a positive operating cash flow.
ALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFALGEV.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of 1.21%, ALGEV is doing worse than 66.06% of the companies in the same industry.
ALGEV has a Return On Equity of 1.52%. This is in the lower half of the industry: ALGEV underperforms 67.89% of its industry peers.
ALGEV's Return On Invested Capital of 0.76% is on the low side compared to the rest of the industry. ALGEV is outperformed by 77.06% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for ALGEV is significantly below the industry average of 8.88%.
Industry RankSector Rank
ROA 1.21%
ROE 1.52%
ROIC 0.76%
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ALGEV.PA Yearly ROA, ROE, ROICALGEV.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 4 6 8

1.3 Margins

With a Profit Margin value of 2.38%, ALGEV is not doing good in the industry: 60.55% of the companies in the same industry are doing better.
ALGEV's Profit Margin has declined in the last couple of years.
The Operating Margin of ALGEV (1.68%) is worse than 76.15% of its industry peers.
ALGEV's Operating Margin has declined in the last couple of years.
ALGEV has a better Gross Margin (63.62%) than 88.99% of its industry peers.
ALGEV's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.68%
PM (TTM) 2.38%
GM 63.62%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
ALGEV.PA Yearly Profit, Operating, Gross MarginsALGEV.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ALGEV is destroying value.
ALGEV has less shares outstanding than it did 1 year ago.
The number of shares outstanding for ALGEV has been reduced compared to 5 years ago.
Compared to 1 year ago, ALGEV has a worse debt to assets ratio.
ALGEV.PA Yearly Shares OutstandingALGEV.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K 800K
ALGEV.PA Yearly Total Debt VS Total AssetsALGEV.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

An Altman-Z score of 3.69 indicates that ALGEV is not in any danger for bankruptcy at the moment.
The Altman-Z score of ALGEV (3.69) is better than 77.98% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that ALGEV is not too dependend on debt financing.
With an excellent Debt to Equity ratio value of 0.03, ALGEV belongs to the best of the industry, outperforming 88.07% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Altman-Z 3.69
ROIC/WACC0.1
WACC7.85%
ALGEV.PA Yearly LT Debt VS Equity VS FCFALGEV.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M

2.3 Liquidity

ALGEV has a Current Ratio of 5.18. This indicates that ALGEV is financially healthy and has no problem in meeting its short term obligations.
ALGEV has a Current ratio of 5.18. This is amongst the best in the industry. ALGEV outperforms 97.25% of its industry peers.
A Quick Ratio of 3.79 indicates that ALGEV has no problem at all paying its short term obligations.
ALGEV's Quick ratio of 3.79 is amongst the best of the industry. ALGEV outperforms 97.25% of its industry peers.
Industry RankSector Rank
Current Ratio 5.18
Quick Ratio 3.79
ALGEV.PA Yearly Current Assets VS Current LiabilitesALGEV.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

ALGEV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -96.89%.
The earnings per share for ALGEV have been decreasing by -17.19% on average. This is quite bad
Looking at the last year, ALGEV shows a small growth in Revenue. The Revenue has grown by 2.81% in the last year.
The Revenue has been growing slightly by 5.90% on average over the past years.
EPS 1Y (TTM)-96.89%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-60.37%
Revenue 1Y (TTM)2.81%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%14.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALGEV.PA Yearly Revenue VS EstimatesALGEV.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
ALGEV.PA Yearly EPS VS EstimatesALGEV.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 395.56, which means the current valuation is very expensive for ALGEV.
Based on the Price/Earnings ratio, ALGEV is valued a bit more expensive than the industry average as 69.72% of the companies are valued more cheaply.
When comparing the Price/Earnings ratio of ALGEV to the average of the S&P500 Index (26.54), we can say ALGEV is valued expensively.
ALGEV is valuated correctly with a Price/Forward Earnings ratio of 13.15.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ALGEV indicates a somewhat cheap valuation: ALGEV is cheaper than 68.81% of the companies listed in the same industry.
ALGEV is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 23.78, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 395.56
Fwd PE 13.15
ALGEV.PA Price Earnings VS Forward Price EarningsALGEV.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

ALGEV's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 13.3
ALGEV.PA Per share dataALGEV.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200 250

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)111.49
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 2.79%, ALGEV has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.65, ALGEV pays a better dividend. On top of this ALGEV pays more dividend than 84.40% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.96, ALGEV pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.79%

5.2 History

The dividend of ALGEV is nicely growing with an annual growth rate of 21.15%!
Dividend Growth(5Y)21.15%
Div Incr Years4
Div Non Decr Years5
ALGEV.PA Yearly Dividends per shareALGEV.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

5.3 Sustainability

117.62% of the earnings are spent on dividend by ALGEV. This is not a sustainable payout ratio.
ALGEV's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP117.62%
EPS Next 2YN/A
EPS Next 3YN/A
ALGEV.PA Yearly Income VS Free CF VS DividendALGEV.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M
ALGEV.PA Dividend Payout.ALGEV.PA Dividend Payout, showing the Payout Ratio.ALGEV.PA Dividend Payout.PayoutRetained Earnings

GEVELOT SA

EPA:ALGEV (12/12/2025, 7:00:00 PM)

178

-1 (-0.56%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryMachinery
Earnings (Last)10-30 2025-10-30
Earnings (Next)N/A N/A
Inst Owners1.21%
Inst Owner ChangeN/A
Ins Owners7.72%
Ins Owner ChangeN/A
Market Cap133.50M
Revenue(TTM)148.53M
Net Income(TTM)3.29M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.79%
Yearly Dividend5.17
Dividend Growth(5Y)21.15%
DP117.62%
Div Incr Years4
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 395.56
Fwd PE 13.15
P/S 0.97
P/FCF N/A
P/OCF 30.9
P/B 0.62
P/tB 0.63
EV/EBITDA 13.3
EPS(TTM)0.45
EY0.25%
EPS(NY)13.53
Fwd EY7.6%
FCF(TTM)-3.7
FCFYN/A
OCF(TTM)5.76
OCFY3.24%
SpS184.19
BVpS288.75
TBVpS284.6
PEG (NY)111.49
PEG (5Y)N/A
Graham Number54.07
Profitability
Industry RankSector Rank
ROA 1.21%
ROE 1.52%
ROCE 1%
ROIC 0.76%
ROICexc 0.85%
ROICexgc 0.87%
OM 1.68%
PM (TTM) 2.38%
GM 63.62%
FCFM N/A
ROA(3y)2.68%
ROA(5y)2.17%
ROE(3y)3.82%
ROE(5y)3.1%
ROIC(3y)3.04%
ROIC(5y)2.57%
ROICexc(3y)3.55%
ROICexc(5y)3.63%
ROICexgc(3y)3.61%
ROICexgc(5y)3.72%
ROCE(3y)3.99%
ROCE(5y)3.37%
ROICexgc growth 3Y-45.56%
ROICexgc growth 5Y-35.96%
ROICexc growth 3Y-45.2%
ROICexc growth 5Y-34.4%
OM growth 3Y-37.75%
OM growth 5Y-26.99%
PM growth 3Y-30.66%
PM growth 5Y-22.17%
GM growth 3Y-1.14%
GM growth 5Y-0.99%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF N/A
Debt/EBITDA 0.85
Cap/Depr 107.05%
Cap/Sales 5.14%
Interest Coverage 250
Cash Conversion 48.26%
Profit Quality N/A
Current Ratio 5.18
Quick Ratio 3.79
Altman-Z 3.69
F-Score6
WACC7.85%
ROIC/WACC0.1
Cap/Depr(3y)120.29%
Cap/Depr(5y)120.78%
Cap/Sales(3y)5.31%
Cap/Sales(5y)6.23%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-96.89%
EPS 3Y-22.49%
EPS 5Y-17.19%
EPS Q2Q%-60.37%
EPS Next Y3.55%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.81%
Revenue growth 3Y10.91%
Revenue growth 5Y5.9%
Sales Q2Q%14.91%
Revenue Next Year3.03%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-81.83%
EBIT growth 3Y-30.96%
EBIT growth 5Y-22.68%
EBIT Next Year84.55%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-180.3%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.26%
OCF growth 3Y-10.1%
OCF growth 5Y-0.33%

GEVELOT SA / ALGEV.PA FAQ

What is the ChartMill fundamental rating of GEVELOT SA (ALGEV.PA) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALGEV.PA.


What is the valuation status of GEVELOT SA (ALGEV.PA) stock?

ChartMill assigns a valuation rating of 2 / 10 to GEVELOT SA (ALGEV.PA). This can be considered as Overvalued.


How profitable is GEVELOT SA (ALGEV.PA) stock?

GEVELOT SA (ALGEV.PA) has a profitability rating of 3 / 10.


Can you provide the financial health for ALGEV stock?

The financial health rating of GEVELOT SA (ALGEV.PA) is 7 / 10.


What is the expected EPS growth for GEVELOT SA (ALGEV.PA) stock?

The Earnings per Share (EPS) of GEVELOT SA (ALGEV.PA) is expected to grow by 3.55% in the next year.